Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study

被引:12
|
作者
Valour, Florent [1 ,2 ]
Bouaziz, Anissa [1 ]
Karsenty, Judith [1 ]
Ader, Florence [1 ,2 ]
Lustig, Sebastien [2 ,3 ]
Laurent, Frederic [2 ,4 ]
Chidiac, Christian [1 ,2 ]
Ferry, Tristan [1 ,2 ]
机构
[1] Hosp Civils Lyon, Groupement Hosp Nord, Serv Malad Infect & Trop, Lyon, France
[2] Univ Lyon 1, INSERM, Int Ctr Res Infect Dis, U1111, Lyon, France
[3] Hosp Civils Lyon, Groupement Hosp Nord, Lyon, France
[4] Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Bacteriol Lab, Lyon, France
关键词
Staphylococcus aureus; Bone and joint infection; Treatment failure; VERTEBRAL OSTEOMYELITIS; ANTIBIOTIC-TREATMENT; CLINICAL-FEATURES; SEPTIC ARTHRITIS; DEBRIDEMENT; RETENTION; IMPACT; ADULT;
D O I
10.1186/1471-2334-14-443
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although methicillin-susceptible Staphylococcus aureus (MSSA) native bone and joint infection (BJI) constitutes the more frequent clinical entity of BJI, prognostic studies mostly focused on methicillin-resistant S. aureus prosthetic joint infection. We aimed to assess the determinants of native MSSA BJI outcomes. Methods: Retrospective cohort study (2001-2011) of patients admitted in a reference hospital centre for native MSSA BJI. Treatment failure determinants were assessed using Kaplan Meier curves and binary logistic regression. Results: Sixty-six patients (42 males [63.6%]; median age 61.2 years; interquartile range [IQR] 45.9-71.9) presented an acute (n = 38; 57.6%) or chronic (n = 28; 42.4%) native MSSA arthritis (n = 15; 22.7%), osteomyelitis (n = 19; 28.8%) or spondylodiscitis (n = 32; 48.5%), considered as "difficult-to-treat" in 61 cases (92.4%). All received a prolonged (27.1 weeks; IQR, 16.9-36.1) combined antimicrobial therapy, after surgical management in 37 cases (56.1%). Sixteen treatment failures (24.2%) were observed during a median follow-up period of 63.3 weeks (IQR, 44.7-103.1), including 13 persisting infections, 1 relapse after treatment disruption, and 2 super-infections. Independent determinants of treatment failure were the existence of a sinus tract (odds ratio [OR], 5.300; 95% confidence interval [CI], 1.166-24.103) and a prolonged delay to infectious disease specialist referral (OR, 1.134; 95% CI 1.013-1.271). Conclusions: The important treatment failure rate pinpointed the difficulty of cure encountered in complicated native MSSA BJI. An early infectious disease specialist referral is essential, especially in debilitated patients or in presence of sinus tract.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Determinants of methicillin-susceptible Staphylococcus aureusnative bone and joint infection treatment failure: a retrospective cohort study
    Florent Valour
    Anissa Bouaziz
    Judith Karsenty
    Florence Ader
    Sébastien Lustig
    Frédéric Laurent
    Christian Chidiac
    Tristan Ferry
    BMC Infectious Diseases, 14
  • [2] Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study
    Quinonez-Flores, Alejandro
    Martinez-Guerra, Bernardo A.
    Roman-Montes, Carla M.
    Tamez-Torres, Karla M.
    Gonzalez-Lara, Maria F.
    Ponce-de-Leon, Alfredo
    Rajme-Lopez, Sandra
    ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [3] Disseminated methicillin-susceptible Staphylococcus aureus infection
    Perkins, David R.
    Hall, James A.
    Lopez, Lisa M.
    Cahuayme-Zuniga, Lizbeth Janice
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (01) : 83 - 86
  • [4] Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections: A Noninferiority Retrospective Cohort Study
    Ganguly, Anisha
    de la Flor, Carolina
    Alvarez, Kristin
    Brown, L. Steven
    Mang, Norman S.
    Smartt, Jillian
    King, Helen
    Perl, Trish M.
    Filizola, Hector
    Bhavan, Kavita P.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (04) : 425 - 431
  • [5] A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia
    Davis, J. S.
    Turnidge, J.
    Tong, S. Y. C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (02) : 297 - 300
  • [6] Delayed antibiotic tailoring on weekends in methicillin-susceptible Staphylococcus aureus bacteraemia: a multicentre retrospective cohort study
    Kumachev, Alexander
    Verma, Amol A.
    Jung, Hae Young
    MacFadden, Derek R.
    Razak, Fahad
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (06) : 922 - 923
  • [7] Cefazolin as second line treatment for invasive Methicillin-Susceptible Staphylococcus aureus infection in a UK cohort of patients
    Young, Bernadette C.
    Dunsmure, Louise
    Downs, Louise
    Kildonaviciute, Kornelija
    Jones, Nicola
    JOURNAL OF INFECTION, 2021, 82 (05) : E25 - E27
  • [8] Antimicrobial-Related Severe Adverse Events during Treatment of Bone and Joint Infection Due to Methicillin-Susceptible Staphylococcus aureus
    Valour, Florent
    Karsenty, Judith
    Bouaziz, Anissa
    Ader, Florence
    Tod, Michel
    Lustig, Sebastien
    Laurent, Frederic
    Ecochard, Rene
    Chidiac, Christian
    Ferry, Tristan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 746 - 755
  • [9] Dynamics of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus carriage in pig farmers: a prospective cohort study
    van Cleef, B. A. G. L.
    van Benthem, B. H. B.
    Verkade, E. J. M.
    van Rijen, M.
    Kluytmans-van den Bergh, M. F. Q.
    Schouls, L. M.
    Duim, B.
    Wagenaar, J. A.
    Graveland, H.
    Bos, M. E. H.
    Heederik, D.
    Kluytmans, J. A. J. W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O764 - O771
  • [10] Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study
    Rubio-Terres, C.
    Garau, J.
    Grau, S.
    Martinez-Martinez, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (06) : 722 - 728